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Although confusions persist in what concerns the terminologies used for de-
scribing the fibroblastoid cells of the stromal compartments, the expression of 
antigens in such cells gradually directs their diagnosis towards a stem/progenitor 
phenotype. The stromal cells with long, slender and moniliform prolongations 
were named “telocytes” (TCs), their cell processes being termed “telopodes”. 
However, the mammary gland TCs were not evaluated for the CD34 expression. 
Thus an in vivo immunohistochemical study was designed; antibodies against 
CD10, CD34, CD117/c-kit and vimentin were applied on human mammary gland 
samples of 8 donor patients. Resident CD34-positive stromal cells positive for the 
TCs morphology were found building consistent stromal networks and enshe-
athing microvessels and excretory units. Such cells were CD10±/c-kit-/vimentin+. 
According to the current concepts regarding the in vivo stem/progenitor cells the 
CD34+ TCs of the mammary stroma could be actors in the mammary stem niche 
and their antigens expression could relate to different stages of differentiation. 
(Folia Morphol 2016; 75, 2: 224–231)
Key words: CD34, telocytes, mesenchymal stromal cells, stem cells
INTRODUCTION
In 2005, light microscopic evidence was obtained 
of fibroblastoid stromal cells with long, thin and 
moniliform processes within the mammary gland 
(MG) stroma [30]; such cells were termed at that 
time interstitial Cajal-like cells (ICLCs). In 2010 the 
Romanian and Italian researchers renamed these cells 
from ICLCs to telocytes (TCs), their processes, long 
of “tens-up to hundreds of [micro]m”, being named 
telopodes [31]. It was unequivocally stated that only 
transmission electron microscopy (TEM) “allows sure 
identification of telocytes, evaluation of the cell-to-
cell interrelationships, and a detailed description of 
the telopodes” [15]. This attitude was kept until 2014 
when it was reinforced that “the features of telocytes 
are obvious only by transmission electron microscopy” 
[42]. In these regards, the initial identification of MG 
ICLCs in light microscopy [30], which keeps as the only 
in situ evidence of MG TCs in human tissue, could raise 
doubts. The only proofs of mammary telocyte-like 
cells resulted after an in vitro experiment of breast 
cancer reconstitution performed recently, in which 
TCs were identified in primary culture cells by phase 
contrast microscope [25], no specific marker being 
used then. Indeed, at this time a specific immune 
phenotype of TCs was not clearly established [34]; 
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although the most used markers which point to TCs, 
but not exclusively, are CD34 and c-kit [15]. 
It was only recently indicated by the Italian re-
searchers that “In the adulthood, TC may be considered 
mesenchymal stromal cells able to differentiate in dif-
ferent cell types, such as the interstitial cells of Cajal, 
the resident myofibroblasts and the fibroblasts” [43].
It was also repeatedly stated that TCs “nurse” 
stem cells (SCs) in the stem cell niches [15, 31, 32, 
47]. However, CD34, as well as CD117/c-kit, are well 
known markers of cells with different levels of stem-
ness [44]. Although CD34 was used for the in vitro 
study of MG TCs [25], that antibody was not applied 
for the in situ evidence of MG ICLCs [30], further 
renamed to TCs. Therefore, we aimed at studying by 
immunohistochemistry the in situ CD34 phenotype 
of the MG spindle-shaped stromal cells in normal 
human tissue.  
MATERIALS AND METHODS
Human mammary gland samples were obtained 
after surgery from 8 female patients with ages varying 
from 46 to 52 years. Informed consent for research 
use of tissues was obtained prior to surgery. Approval 
for the present study was granted by the institutional 
(2nd affiliation, author #1) Bioethics Committee. 
All experiments on human subjects were conduct-
ed in accordance with the Declaration of Helsinki 
(http://www.wma.net/en/30publications/10policies/
b3/index).  
Mammary samples were fixed immediately after 
removal, kept for 24 h in buffered formalin (8%), and 
then processed with an automatic histoprocessor 
(Diapath, Martinengo, BG, Italy) with paraffin em-
bedding. Sections were cut manually at 3 μm, and 
were mounted on SuperFrost® electrostatic slides for 
immunohistochemistry (Thermo Scientific, Menzel- 
-Gläser, Braunschweig, Germany).
The following anti-human primary antibodies 
were used: (a) anti-CD34 (clone QBEnd/10, Biocare 
Medical, Concord, CA, USA); (b) anti-CD10 (clone 
56C6, Biocare Medical, Concord, CA, USA); (c) anti-
CD117/c-kit (clone Y145, Biocare Medical, Concord, 
CA, USA); (d) anti-vimentin (clone SP20, Biocare Med-
ical, Concord, CA, USA).
For CD34 labelling, tissues were deparaffinised 
and hydrated, then endogenous peroxidase was 
blocked using Peroxidazed 1 (Biocare Medical, Con-
cord, CA, USA). Carezyme I —Trypsin was used for en-
zyme digestion. Endogenous biotin was blocked and 
background blocker was applied to reduce non-spe-
cific background staining. The primary antibody was 
applied at a dilution of 1:100, at room temperature, 
for 60 min. Then a two-step horseradish peroxidase 
(HRP) detection method using the 4plus detection 
system was applied, and a HRP-compatible chromo-
gen diaminobenzidine (DAB) was applied. Sections 
were counterstained with haematoxylin and rinsed 
with deionised water. For washing steps was used 
tris-buffered saline (TBS) solution, pH 7.6. 
For CD10 labelling, tissues were deparaffinised 
and rehydrated, then endogenous peroxidase was 
blocked using Peroxidased 1 (Biocare Medical, Con-
cord, CA, USA). For the heat induced epitope re-
trieval was used the Decloaking Chamber (Biocare 
Medical, Concord, CA, USA) and retrieval solution 
pH 6 (Biocare Medical, Concord, CA, USA), the latter 
being a buffer specially formulated for superior pH 
stability at high temperatures. Background blocker 
(Biocare Medical, Concord, CA, USA) was used to 
reduce non-specific background staining. The pri-
mary antibody was applied at a dilution of 1:40. 
As detection system was used MACH 4 (Biocare 
Medical, Concord, CA, USA) which is a two-step 
(probe/polymer) universal HRP detection method. 
A HRP-compatible chromogen (DAB) was applied. 
Sections were counterstained with haematoxylin 
and rinsed with deionised water. For washing steps 
was used TBS solution, pH 7.6.
For CD117/c-kit labelling, tissues were deparaffin-
ised and rehydrated, then endogenous peroxidase 
was blocked using Peroxidased 1 (Biocare Medical, 
Concord, CA, USA). For the heat induced epitope 
retrieval was used the Decloaking Chamber (Biocare 
Medical, Concord, CA, USA) and retrieval solution pH 6 
(Biocare Medical, Concord, CA, USA). Background 
blocker (Biocare Medical, Concord, CA, USA) was 
used to reduce non-specific background staining. 
The primary antibody was applied at a dilution of 
1:200. As detection system was used MACH 2 rabbit 
HRP polymer detection (Biocare Medical, Concord, 
CA, USA) which consists of a single reagent ap-
plied after the primary antibody. A HRP-compati-
ble chromogen (DAB) was applied. Sections were 
counterstained with haematoxylin and rinsed with 
deionised water. For washing steps was used TBS 
solution, pH 7.6.
For vimentin labelling was used the same protocol 
as for CD117/c-kit, the primary antibody being used 
at a dilution of 1:200.
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RESULTS
The normal structure of the mammary sam-
ples was evaluated on the haematoxylin and eo-
sin-stained slides and on the haematoxylin-stained 
control slides (Figs. 1, 2). Terminal duct lobular 
units consisting of terminal ductules, intralobular 
collecting ducts and the intralobular stroma were 
separated by fibrous interlobular tissue built-up by 
densely packed collagen fibres and embedded cells 
of fibroblastoid shapes. The fibroblastoid cells of the 
MG stroma presented long and extremely long cell 
processes serially linking the cells along the collagen 
bundles (Fig. 1). Prolongations of the stromal cells 
were dichotomous (Fig. 2).
On CD34-labelled slides both the intralobular and 
interlobular stromal compartments were found rich 
in immune positive fibroblastoid cells (Figs. 3, 4) with 
long (tens of micrometres) moniliform cell processes, 
which were building consistent networks. Being seri-
ally linked, these stromal CD34-positive cells ensured 
cellular paths of stromal transmission of hundreds 
of micrometres. Although such stromal cells were 
also neighbouring microvessels they were accurately 
distinguished of the CD34-positive vascular endothe-
lial cells (Fig. 5). Moreover, the CD34-positive cells 
building stromal networks were projecting processes 
upon the perivascular ones (Fig. 5) thus integrating 
Figure 1. Internal negative control of CD34 labelling on normal 
mammary samples, haematoxylin-stained. Serially linked fibro- 
blastoid stromal cells with long and moniliform prolongations  
are identified (inset, zoomed-in).
Figure 2. Internal negative control of CD34 labelling on normal 
mammary samples, haematoxylin-stained. The fibroblastoid cells 
of the interlobular stroma have dichotomous prolongations (arrows, 
zoomed-in inset). 
Figure 3. CD34 labelling of normal mammary samples. The thin 
white arrows indicate mammary excretory units, the thick white 
arrows indicate excretory ducts and the black arrows point to  
a consistent stromal network of CD34-positive fibroblastoid  
stromal cells. Digitally reconstructed image (9 micrographs).
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these later into a general network. Around the ex-
cretory units the CD34-positive stromal cells were 
usually building multilayered sheaths. The intralobular 
CD34-positive cells displayed shorter prolongations 
and were building coverings, usually single-layered, 
around the ductules.
CD10 labelled the ductal myoepithelial cells and 
also a subset of inter- and intralobular fibroblastoid 
stromal cells; morphologically identical stromal cells 
were however CD10-negative (Fig. 6). 
CD117/c-kit labelled the terminal ductules, the 
luminal cells of the ducts and stromal mast cells; other 
stromal cells were negative for this antibody (Fig. 7).
Vimentin labelled the myoepithelial cells of ducts 
and the microvascular endothelia; the stromal fibro-
blastoid cells labelling resulted positive (Fig. 8).
Figure 7. CD117/c-kit labelling of normal mammary samples. 
Epithelia of terminal ducts (arrowheads) and stromal mast cells 
(arrows) are the only positively labelled elements.
Figure 4. CD34 labelling of normal mammary samples. CD34-posi-
tive stromal fibroblastoid cells (arrows) are serially linked.
Figure 5. CD34 labelling of normal mammary samples. Perivascular 
CD34-positive spindle-shaped cells with long prolongations are 
indicated (arrows, A, B); similar cells are collagen-embedded, 
build networks in the perivascular stroma (polygonal shape, A) and 
project prolongations (arrowhead, A) on the perivascular ones. The 
perivascular CD34-positive cells are distinctive of the CD34-posi-
tive vascular endothelial cells (zoomed-in inset, B).
Figure 6. CD10 labelling of normal mammary samples. The ductal 
myoepithelial cells are CD10-positive (arrowheads). The intra-
lobular stromal cells are either CD10-positive (black arrows),  
or CD10-negative (white arrows).
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DISCUSSION
A recent study [6] was focused upon CD34-pos-
itive “fibrocytes” of the MG stroma. It was evaluat-
ed there the stromal loss of CD34 expression and 
acquisition of smooth muscle actin phenotype as 
a condition for invasiveness of breast carcinoma. The 
authors document there a series of papers referring 
to the bone marrow-derived circulating fibrocytes 
firstly described by Bucala et al. [4], which are defined 
as acting in reparatory processes and presenting 
a combined, mesenchymal, haematopoietic and stro-
mal phenotype (e.g.CD34+/CD45+/vimentin and/or 
collagen I, collagen III, alpha-smooth muscle actin) 
[36]. The authors distinguish the circulating fibrocytes 
of constitutional fibrocytes already present within the 
stromal compartment and available for phenotypic 
changes during the reparatory processes. The dis-
tinction between resident and circulating CD34-pos-
itive fibrocytes was clearly indicated by Diaz-Flores et 
al. [13], who brought convincing arguments when 
claiming that CD34-positive stromal fibroblastic/fi-
brocytic cells are, no matter the different names they 
were given by different research groups, a subset 
of stromal cells which “in addition to having the 
general functions of fibroblasts, behave as native 
mesenchymal stem cell progenitors (after losing CD34 
expression), regulate the growth, maturation and 
differentiation of adjacent cells, and participate in 
immunomodulation”. In their analysis, Diaz-Flores et 
al. (2014) [13] included not only the fibrocytes, but 
also the TCs, a stromal cell subtype only defined by 
a morphological pattern: “cells with telopodes” [3, 29], 
these later being long, slender and moniliform cell 
prolongations [37–39]. Unfortunately, although TCs 
are consistently investigated, and it was suggested 
that they could, as well, be either resident, or bone 
marrow-derived cells with that peculiar morphology 
[38], the existing studies did not yet take into account 
that instead of being “nurses” for the neighbouring 
stem cells (see also Introduction) TCs could be transit 
amplifying cells (TACs) deriving from neighbour stem 
cells, which would justify their positive CD34 and c-kit 
phenotypes. This is convergent with theories indicating 
that TCs behave as progenitor cells [11–13], thus TACs.
The mammary TCs were initially evaluated exclu-
sively by means of light microscopy, with methylene 
blue and c-kit stains [30] and were viewed then as 
c-kit-positive ICLCs. They were not searched then for 
the CD34 expression. It was documented that, in 
human chorial villi, some TCs are CD34-positive, some 
are c-kit-positive [15, 41]. Here a CD34-positive but 
c-kit-negative phenotype was found. This reinforces 
the observation of Diaz-Flores et al. (2014) [13] that 
such stromal cells behave like stem/progenitor cells 
after losing the CD34 expression. In these regards, the 
CD34 and the CD117/c-kit phenotypes are reciprocally 
exclusive in stromal fibroblastoid cells.  
Mesenchymal stem cells (MSCs) selectively pro-
liferate to tumours and contribute to the formation 
of tumour-associated stroma [16]; bone marrow-de-
rived MSCs cause the cancer cells, in human, to in-
crease their metastatic potency [19]. Except MSCs, 
adult marrow also contains haematopoietic stem 
cells (HSCs) and endothelial progenitor cells [1]. To 
establish a MSC diagnosis, in vitro experiments are 
needed to evaluate the plastic-adherence of the col-
onies. Actually, the concept of MSCs is becoming 
increasingly obscure and the exact identity of MSCs 
in vivo is not yet clear [21, 24, 35]. On other hand, 
endothelial progenitor cells usually express c-kit and 
CD34, a phenotype which was also described for 
TCs (see Introduction) but was not discussed against 
a stem cell diagnosis. In this regard, the CD34-pos-
itive but CD117/c-kit negative phenotype we found 
Figure 8. Vimentin labelling of normal mammary samples. Stromal 
fibroblastoid cells with long prolongations express vimentin. Inset: 
magnified detail.
229
N. Petre et al., CD34+ mammary stromal cells
in this study can indicate rejection of an endothelial 
tip cell diagnosis, HSCs being already rejected when 
the stromal compartment is observed. This reinforc-
es a mesenchymal stem/progenitor phenotype of 
the stromal mammary fibroblastoid cells we studied, 
which is supported by recent experiments in which 
TCs were found positive for CD29 [3], a known MSCs 
marker [26, 46]. 
The vimentin-negative phenotype we found for 
the mammary stromal fibroblastoid cells is able to ex-
clude a diagnosis of circulating fibrocytes and thus to 
characterise the cell population we studied as resident 
(constitutional). When TCs pattern was defined [31] 
cytoskeletal elements, such as thin and intermediate 
filaments were included; further studies documented 
the expression of vimentin in TCs [15]. This could 
equally indicate a progenitor or a fibroblastic phe-
notype, and does not bring so much in the cell type 
identification. 
The human adipose-derived MSCs result from the 
stromal vascular fraction of adipose tissue but actually 
their specific surface markers, morphology and in vivo 
location are still debated [40]. These cells were found 
to represent a heterogeneous cell population, most of 
them constitutively expressing PDGFR and CD10 but 
variably expressing alpha-SMA, c-kit, Oct4 and CD68 
[40]. The expression of CD10 in MSCs was reported 
either positive, or negative [5, 14, 22, 28, 33]. In the 
present study, the CD10 expression in the mammary 
samples was heterogeneous, positive or negative, as 
compared with the homogenous expression of CD34. 
This can relate to different stages of acquisition of 
the MSC phenotype in these cells. The assignment of 
CD10 only to a subset of MSCs was assessed by an 
in vitro study [2]. The CD10-positive phenotype was 
mostly encountered in the vicinity of the mammary 
vessels and excretory units. This is in accordance with 
the observations of Kim et al. [20], in human foetuses, 
that, similar to CD34, CD10 may be expressed not only 
in epithelial, but also in juxtaepithelial mesenchymal/
stromal tissues.
We found here multilayered sheaths of CD34-pos-
itive stromal cells wrapping around microvessels and 
excretory units, connected to the CD34-positive stro-
mal networks. Guido Majno pointed in 1965 [18, 
23] to cells of the perivascular niche with “proto-
plasmic expansions wrapped around the vessels”. 
He termed these cells “veil cells” and these were 
further assumed to serve several main functions, fi-
brogenesis, phagocytosis, barrier function, and signal 
conduction [17, 45]. The veil cells of Majno [23] are 
fibroblastoid cells with a mesenchymal appearance 
which can be associated with MSCs potentialities [27]. 
This is consistent with continuously adding evidence 
which indicate that adult stem niches are, actually, 
perivascular [7–10, 48].
However, further exploration of MG TCs TEM is 
mandatory, as it could indicate, or not, ultrastruc-
tural peculiarities relating the mammary TCs to stem/ 
/progenitor cells. Of clinical interest remains the MG 
stromal stem niche contribution in various types of 
breast cancer; this could be a difficult task, as the 
contribution of bone marrow to stromal compart-
ments is beyond any doubts and will thus blur a clear 
identification.
CONCLUSIONS
In conclusion, according to their morphology (e.g. 
the spindle shape, and the long, slender and monili-
form prolongations linking the cells into stromal net-
works) the CD34+/CD10±/c-kit-/vimentin-cells of the 
human mammary inter- and intralobular stroma could 
qualify as being TCs. However, their MSC potentiality 
is strongly suggested by their immune phenotypes. 
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